11.54
+0.49
+(4.43%)
At close: April 17 at 4:00:03 PM EDT
11.54
0.00
(0.00%)
After hours: April 17 at 4:25:42 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
---|---|---|---|
GALLAGHER NEIL Officer | Sale | Feb 10, 2025 | 85,095 |
GOLDAN KEITH ALAN Chief Financial Officer | Sale | Feb 10, 2025 | 90,746 |
HUBER MARTIN H JR Director | Stock Award(Grant) | Feb 5, 2025 | 74,000 |
JARRETT A JENNIFER Director | Stock Award(Grant) | Feb 5, 2025 | 90,000 |
KATKIN KEITH A Director | Stock Award(Grant) | Feb 5, 2025 | 90,000 |
LEGAULT PIERRE Director | Stock Award(Grant) | Feb 5, 2025 | 90,000 |
METZGER MICHAEL A Chief Executive Officer | Conversion of Exercise of derivative security | Mar 14, 2025 | 306,195 |
MEURY WILLIAM Director | Stock Award(Grant) | Feb 5, 2025 | 90,000 |
PODLESAK DENNIS G Director | Stock Award(Grant) | Feb 5, 2025 | 191,763 |
RIZO ALEKSANDRA M.D. PH.D. Director | Stock Award(Grant) | Feb 5, 2025 | 25,000 |
Related Tickers
KURA Kura Oncology, Inc.
5.90
+2.61%
MRUS Merus N.V.
43.06
+2.73%
CRNX Crinetics Pharmaceuticals, Inc.
30.42
+2.84%
IMCR Immunocore Holdings plc
28.41
+1.94%
SRRK Scholar Rock Holding Corporation
30.75
+3.33%
SWTX SpringWorks Therapeutics, Inc.
37.92
+0.48%
EWTX Edgewise Therapeutics, Inc.
13.45
+3.22%
IDYA IDEAYA Biosciences, Inc.
17.08
+5.56%
DAWN Day One Biopharmaceuticals, Inc.
6.84
+1.18%
ZVRA Zevra Therapeutics, Inc.
7.15
+1.42%